How brain inflammation affects recovery after traumatic brain injury
Behavioral and axonal impacts of thalamic microglial process convergence following diffuse brain injury
This study is looking at how special immune cells in the brain, called microglia, help with healing after a traumatic brain injury, using a pig model that acts like a human brain, to find ways to improve recovery for people with TBI.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-10590783 on NIH RePORTER |
What this research studies
This research investigates the role of microglia, the brain's immune cells, in the recovery process following traumatic brain injury (TBI). It focuses on how these cells interact with injured axons in the thalamus, particularly in a pig model that closely resembles human brain structure and function. By examining the relationship between microglial activity and behavioral outcomes like anxiety and sensory sensitivity, the study aims to uncover mechanisms that could lead to improved recovery strategies for TBI patients. The research utilizes advanced methodologies to assess both the biological and behavioral impacts of TBI in a pre-clinical setting.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have experienced traumatic brain injuries.
Not a fit: Patients who have not suffered a traumatic brain injury or those with pre-existing neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance recovery and reduce anxiety in patients with traumatic brain injuries.
How similar studies have performed: While research on microglial processes in rodents has been conducted, this approach using pig models to study TBI and its effects on human-like brain structures is relatively novel.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Lafrenaye, Audrey D — Virginia Commonwealth University
- Study coordinator: Lafrenaye, Audrey D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.